AI tools can help reduce anxiety and depression symptoms, Israeli study finds

A conversational artificial intelligence (AI) platform developed in Israel can significantly reduce symptoms of anxiety and depression, establish a meaningful therapeutic alliance with users, and provide continuous emotional support. Researchers at Reichman University in Herzliya published their findings in JAMA Network Open, demonstrating the AI's efficacy.

The study, led by Prof. Anat Shoshani, explored AI's potential to address the global mental health crisis. The Kai.ai platform uses therapeutic techniques like cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT) to act as a conversational companion. It guides users through mood tracking, journaling, stress management, and scientifically backed exercises via messaging apps like WhatsApp.

“

Efficacy of a conversational AI agent for psychiatric symptoms and digital therapeutic alliance: A randomized clinical trial.

During a period of heightened security tensions in Israel, nearly 1,000 students experiencing emotional distress participated in a randomized clinical trial. The results showed that users of the AI platform experienced a significant reduction in anxiety and depression symptoms compared to a wait-list control group. Notably, the AI even outperformed human-led group therapy in reducing anxiety, with 58% of participants with clinical anxiety moving into the healthy range.

One of the most striking findings was the AI's ability to form a "therapeutic alliance." Participants rated the system as empathetic, professional, and supportive, comparable to human therapists. Many found it easier to open up to the digital system, free from concerns about judgment.

“

empathetic, professional, and supportive at levels comparable to human therapists.